- ISIN
- US4333131039
- Sector
- Healthcare
- Industry
- Health Information Services
- IPO Date
- May 22, 2025
Highlights
- Market Cap
- $5.78B
- Enterprise Value
- $5.61B
- EPS (TTM)
- -$6.23
- Total Revenue (TTM)
- $646.34M
- Gross Profit (TTM)
- $522.22M
- EBITDA (TTM)
- -$514.46M
- Year Range
- $30.08 - $91.50
- Target Price
- $56.88
- ROA (TTM)
- -70.02%
- ROE (TTM)
- -456.88%
- Avg. Volume (1M)
- 2M
- Avg. Volume Value (1M)
- $129.28M
Share Price Chart
Loading charts...
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
HNGE Performance Chart
Hinge Health, Inc (HNGE) is up 60.8% since the beginning of the year. At $75 per share, HNGE is trading 18.3% below its 52-week high of $92.
Loading charts...
Compare this symbol against anything
Returns By Period
Hinge Health, Inc (HNGE) has returned 60.84% so far this year and 66.21% over the past 12 months.
Hinge Health, Inc
- 1D
- -0.53%
- 1M
- -11.11%
- 6M
- 114.07%
- YTD
- 60.84%
- 1Y
- 66.21%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
- ALL TIME*
- 71.68%
Benchmark (S&P 500 Index)
- 1D
- 0.70%
- 1M
- 0.09%
- 6M
- 7.94%
- YTD
- 9.41%
- 1Y
- 20.07%
- 3Y*
- 17.84%
- 5Y*
- 11.25%
- 10Y*
- 13.26%
- ALL TIME*
- 8.09%
HNGE Monthly Returns History
Based on dividend-adjusted daily data since May 22, 2025, HNGE's average daily return is +0.29%, while the average monthly return is +6.21%. At this rate, an investment would double in approximately 1.0 years.
Historically, 47% of months were positive and 53% were negative. The best month was Jun 2026 with a return of +47.7%, while the worst month was Jan 2026 at -24.9%. The longest winning streak lasted 3 consecutive months, and the longest losing streak was 3 months.
On a daily basis, HNGE closed higher 53% of trading days. The best single day was Aug 6, 2025 with a return of +25.6%, while the worst single day was Nov 5, 2025 at -15.1%.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -24.87% | 22.52% | -9.82% | 15.66% | 26.03% | 47.66% | -9.99% | 60.84% | |||||
| 2025 | -1.04% | 33.24% | -13.14% | 24.76% | -12.48% | 1.39% | -1.71% | -5.03% | 18.34% |
Benchmark Metrics
Hinge Health, Inc has an annualized alpha of 57.62%, beta of 1.27, and R2 of 0.06 versus S&P 500 Index. Calculated based on daily prices since May 22, 2025.
- This stock captured 96.09% of S&P 500 Index gains and tended to rise during its downturns (downside capture of -755.59%) - a profile typical of hedging or uncorrelated assets.
- R2 of 0.06 means this stock moves largely independently of S&P 500 Index - capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.
- Alpha
- 57.62%
- Beta
- 1.27
- R²
- 0.06
- Upside Capture
- 96.09%
- Downside Capture
- -755.59%
Return for Risk
Risk / Return Rank
HNGE ranks 75 for risk / return — above 75% of stocks peers on PortfoliosLab. Its historical combined result is above most peers.
Risk / Return Metrics
The table below present risk-adjusted performance metrics for Hinge Health, Inc (HNGE) and compare them to S&P 500 Index.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| HNGE | Benchmark | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.32 | ||
| Sortino ratioReturn per unit of downside risk | -0.09 | ||
| Omega ratioGain probability vs. loss probability | 1.24 | 1.25 | -0.01 |
| Calmar ratioReturn relative to maximum drawdown | 1.37 | 2.00 | -0.63 |
| Martin ratioReturn relative to average drawdown | 3.03 | 8.49 | -5.46 |
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading charts...
Worst Drawdowns
The table below displays the maximum drawdowns of the Hinge Health, Inc. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Hinge Health, Inc was 48.52%, occurring on Feb 6, 2026. Recovery took 78 trading sessions.
The current Hinge Health, Inc drawdown is 16.99%.
Drawdown | Fall | Recovery | Underwater | Related event |
|---|---|---|---|---|
-48.52%Feb 2026 | 6mo 3d | 3mo 25d | 9mo 28dAug 2025 - Jun 2026 | — |
-17.71%Jul 2026 | 15d | — | 20dJul 2026 - now | — |
-17.28%Jun 2025 | 16d | 10d | 26dMay 2025 - Jun 2025 | 2025 selloff2025 |
-16.77%Jul 2025 | 6d | 1mo | 1mo 6dJul 2025 - Aug 2025 | — |
-5.09%Jun 2025 | 1d | 5d | 5dJun 2025 - Jun 2025 | 2025 selloff2025 |
Drawdown Indicators
| HNGE | Benchmark | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -48.52% | -56.78% | +8.26% |
Max Drawdown (1Y)Largest decline over 1 year | -48.52% | -9.10% | -39.42% |
Max Drawdown (3Y)Largest decline over 3 years | — | -18.90% | — |
Max Drawdown (5Y)Largest decline over 5 years | — | -25.43% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -33.92% | — |
Current DrawdownCurrent decline from peak | -16.99% | -1.58% | -15.41% |
Average DrawdownAverage peak-to-trough decline | -16.72% | -10.70% | -6.02% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.93% | 2.14% | +19.79% |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading charts...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Hinge Health, Inc over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Hinge Health, Inc is priced in the market compared to other companies in the Health Information Services industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for HNGE relative to other companies in the Health Information Services industry. Currently, HNGE has a P/S ratio of 9.5. This P/S ratio is high relative to other companies in the industry. It could mean the stock is overvalued, or that investors expect strong future growth and profitability.
Income Statement
| TTM | |
|---|---|
Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |
Build a portfolio with HNGE
Add Hinge Health, Inc to a portfolio and analyze allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Analyzer with HNGE